Anish Suri

Contact Anish

Anish Suri

President & Chief Scientific Officer

Cue Biopharma

Anish Suri is an immunologist with extensive experience in basic and translational research focused on immuno-oncology, autoimmune disorders, transplantation rejection, and inflammation. Prior to joining Cue Biopharma, he held roles of increasing responsibility at Janssen Pharmaceutical Companies, including a key leadership position overseeing strategic Immunoscience initiatives. Prior to Janssen, he was responsible for providing strategic guidance to immuno-oncology and immunology drug discovery programs at Bristol-Myers Squibb Pharmaceutical Research Institute. Prior to his work in the pharmaceutical industry, Dr. Suri was Assistant Professor of Pathology and Immunology at Washington University School of Medicine. He received his Ph.D. in immunology from Washington University in St Louis, Missouri.

Talks About
#science #biologics

Preferred Locations
#Northamerica

Speaking Engagements

2nd FC Receptor & IgG Targeted Therapies Summit

Paid

The 2nd Fc Receptor & IgG Targeted Therapies Summit is your definitive meeting for the most up-to-date clinical and commercial developments on pioneering strategies to modulate FcRs and harness their full therapeutic potential.

26-28 April 2022

Healthcare

5th Treg Summit

Paid

Join us at the 5th Treg Summit, where we will be discussing the latest advancements in IL-2 and CAR-Treg therapies, and how advanced engineering and product design can enhance their tissue specificity, durability, stability, and safety, thus accelerating their clinical translation.

With investment in the Treg field at an all-time high, the

30 May-01 June 2023

Healthcare

14th World Bispecific Summit 2023

Paid

Join us for the 14th World Bispecific Summit in 2023, where we celebrate the remarkable advancements and immense potential of bispecific antibody treatments. In this pivotal year, bispecific antibody therapies have emerged as formidable contenders in the field, rivaling cell therapy as a transformative approach in healthcare. With an increasing num

02-04 October 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Anish Suri

President & Chief Scientific Officer

Speaking Engagements

2nd FC Receptor & IgG Targeted Therapies Summit

5th Treg Summit

14th World Bispecific Summit 2023